Homeostatic MyD88-dependent signals cause lethal inflammation in the absence of A20

被引:234
作者
Turer, Emre E. [1 ]
Tavares, Rita M. [1 ,2 ]
Mortier, Erwan [1 ]
Hitotsumatsu, Osamu [1 ]
Advincula, Rommel [1 ]
Lee, Bettina [1 ]
Shifrin, Nataliya [1 ]
Malynn, Barbara A. [1 ]
Ma, Averil [1 ]
机构
[1] Univ Calif San Francisco, Gastrointestinal Div, Dept Med, Program Biomed Sci, San Francisco, CA 94143 USA
[2] Inst Gulbenkian Ciencias, P-2781901 Oeiras, Portugal
关键词
D O I
10.1084/jem.20071108
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Toll-like receptors (TLRs) on host cells are chronically engaged by microbial ligands during homeostatic conditions. These signals do not cause inflammatory immune responses in unperturbed mice, even though they drive innate and adaptive immune responses when combating microbial infections. A20 is a ubiquitin-modifying enzyme that restricts exogenous TLR-induced signals. We show that MyD88-dependent TLR signals drive the spontaneous T cell and myeloid cell activation, cachexia, and premature lethality seen in A20-deficient mice. We have used broad spectrum antibiotics to demonstrate that these constitutive TLR signals are driven by commensal intestinal flora. A20 restricts TLR signals by restricting ubiquitylation of the E3 ligase tumor necrosis factor receptor-associated factor 6. These results reveal both the severe proinflammatory pathophysiology that can arise from homeostatic TLR signals as well as the critical role of A20 in restricting these signals in vivo. In addition, A20 restricts MyD88-independent TLR signals by inhibiting Toll/interleukin 1 receptor domain-containing adaptor inducing interferon (IFN) beta-dependent nuclear factor kappa B signals but not IFN response factor 3 signaling. These findings provide novel insights into how physiological TLR signals are regulated.
引用
收藏
页码:451 / 464
页数:14
相关论文
共 46 条
[1]   Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function [J].
Adachi, O ;
Kawai, T ;
Takeda, K ;
Matsumoto, M ;
Tsutsui, H ;
Sakagami, M ;
Nakanishi, K ;
Akira, S .
IMMUNITY, 1998, 9 (01) :143-150
[2]   Control of adaptive immune responses by Toll-like receptors [J].
Barton, GM ;
Medzhitov, R .
CURRENT OPINION IN IMMUNOLOGY, 2002, 14 (03) :380-383
[3]   Toll-like receptor signaling pathways [J].
Barton, GM ;
Medzhitov, R .
SCIENCE, 2003, 300 (5625) :1524-1525
[4]   The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses [J].
Boone, DL ;
Turer, EE ;
Lee, EG ;
Ahmad, RC ;
Wheeler, MT ;
Tsui, C ;
Hurley, P ;
Chien, M ;
Chai, S ;
Hitotsumatsu, O ;
McNally, E ;
Pickart, C ;
Ma, A .
NATURE IMMUNOLOGY, 2004, 5 (10) :1052-1060
[5]   ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance [J].
Brint, EK ;
Xu, DM ;
Liu, HY ;
Dunne, A ;
McKenzie, ANJ ;
O'Neill, LAJ ;
Liew, FY .
NATURE IMMUNOLOGY, 2004, 5 (04) :373-379
[6]   Dynamic imaging of dendritic cell extension into the small bowel lumen in response to epithelial cell TLR engagement [J].
Chieppa, Marcello ;
Rescigno, Maria ;
Huang, Alex Y. C. ;
Germain, Ronald N. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (13) :2841-2852
[7]   Rip1 mediates the Trif-dependent Toll-like receptor 3- and 4-induced NF-κB activation but does not contribute to interferon regulatory factor 3 activation [J].
Cusson-Hermance, N ;
Khurana, S ;
Lee, TH ;
Fitzgerald, KA ;
Kelliher, MA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (44) :36560-36566
[8]   Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain [J].
Deng, L ;
Wang, C ;
Spencer, E ;
Yang, LY ;
Braun, A ;
You, JX ;
Slaughter, C ;
Pickart, C ;
Chen, ZJ .
CELL, 2000, 103 (02) :351-361
[9]   IRF3 mediates a TLR3/TLR4-specific antiviral gene program [J].
Doyle, SE ;
Vaidya, SA ;
O'Connell, R ;
Dadgostar, H ;
Dempsey, PW ;
Wu, TT ;
Rao, G ;
Sun, R ;
Haberland, ME ;
Modlin, RL ;
Cheng, G .
IMMUNITY, 2002, 17 (03) :251-263
[10]   IKKε and TBK1 are essential components of the IRF3 signaling pathway [J].
Fitzgerald, KA ;
McWhirter, SM ;
Faia, KL ;
Rowe, DC ;
Latz, E ;
Golenbock, DT ;
Coyle, AJ ;
Liao, SM ;
Maniatis, T .
NATURE IMMUNOLOGY, 2003, 4 (05) :491-496